Sean Wieland
Stock Analyst at Piper Sandler
(1.87)
# 3,236
Out of 5,058 analysts
31
Total ratings
45.45%
Success rate
1.34%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Overweight | $57 → $55 | $34.53 | +59.28% | 12 | Aug 11, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $35 → $36 | $22.55 | +59.67% | 3 | Aug 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $3.93 | +2,953.44% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $35.83 | -83.25% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $48.00 | -8.33% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $217.48 | +6.22% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $7.05 | +4,027.66% | 5 | Feb 25, 2021 |
Omnicell
Aug 11, 2025
Maintains: Overweight
Price Target: $57 → $55
Current: $34.53
Upside: +59.28%
Privia Health Group
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $36
Current: $22.55
Upside: +59.67%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $3.93
Upside: +2,953.44%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $35.83
Upside: -83.25%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $48.00
Upside: -8.33%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $217.48
Upside: +6.22%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $7.05
Upside: +4,027.66%